LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 46.22 | 27.76 | 230 | 4125 | 0.0558 | 0.3405 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 46.22 | 27.76 | 1757 | 4125 | 0.4259 | 0.7769 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 47.93 | 27.76 | 66 | 4421 | 0.0149 | 0.1257 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 47.93 | 27.76 | 1479 | 4421 | 0.3345 | 0.7219 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 47.93 | 27.76 | 265 | 4421 | 0.0599 | 0.3613 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 47.93 | 27.76 | 1818 | 4421 | 0.4112 | 0.7712 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 49.63 | 27.76 | 78 | 4818 | 0.0162 | 0.1490 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 49.63 | 27.76 | 1544 | 4818 | 0.3205 | 0.7163 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 49.63 | 27.76 | 265 | 4818 | 0.0550 | 0.3543 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 49.63 | 27.76 | 1888 | 4818 | 0.3919 | 0.7634 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 51.33 | 27.76 | 80 | 5117 | 0.0156 | 0.1510 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 51.33 | 27.76 | 1591 | 5117 | 0.3109 | 0.7125 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 51.33 | 27.76 | 283 | 5117 | 0.0553 | 0.3614 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 51.33 | 27.76 | 1965 | 5117 | 0.3840 | 0.7612 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 53.04 | 27.76 | 93 | 5365 | 0.0173 | 0.1726 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 53.04 | 27.76 | 1662 | 5365 | 0.3097 | 0.7140 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 53.04 | 27.76 | 316 | 5365 | 0.0589 | 0.3775 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 53.04 | 27.76 | 2074 | 5365 | 0.3865 | 0.7647 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 54.74 | 27.76 | 95 | 5606 | 0.0169 | 0.1743 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 54.74 | 27.76 | 1732 | 5606 | 0.3089 | 0.7156 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 54.74 | 27.76 | 333 | 5606 | 0.0594 | 0.3833 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 54.74 | 27.76 | 2119 | 5606 | 0.3780 | 0.7614 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 56.45 | 27.76 | 112 | 5745 | 0.0195 | 0.1988 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 56.45 | 27.76 | 1809 | 5745 | 0.3149 | 0.7211 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 56.45 | 27.76 | 377 | 5745 | 0.0656 | 0.4037 | MN20160318_Q01 | L17 |